Suicide risk and prevention during the COVID-19 pandemic
David Gunnella b✉, David Gunnella c, Louis Applebyc d, Ella Arensmand e, Keith E Hawtone f, Ann Johnc f, Navneet Kapurc g, Murad Khang h, Rory C. O’Connorh i, Jane Pirkisi, Louis Applebyc, Ella Arensmand, Eric D Cainej, Shu‐Sen Changj, Shu-Sen Changj, Ying-Yeh Chenj, Helen Christensenj, Rakhi Dandonaj, Michael Eddlestonj, Annette Erlangsenj, David Gunnella✉, David Gunnella, Jill Harkavy-Friedmanj, Keith E Hawtone, Ann Mary Johnf, Navneet Kapurc, Murad Khang, Olivia J Kirtleyj, Duleeka W. Knipej, Flemming Konradsenj and 25 others
- aNational Institute for Health Research Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol BS8 2PS, UK. Electronic address: d.j.gunnell@bristol.ac.uk
- bNational Institute for Health Research Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol BS8 2PS, UK
- cCentre for Mental Health and Safety, National Institute for Health Research Greater Manchester Patient Safety Translational Research Centre, Manchester Academic Health Sciences Centre, University of Manchester and Greater Manchester Mental Health NHS Foundation Trust. Manchester, UK
- dSchool of Public Health and National Suicide Research Foundation, College of Medicine and Health, University College Cork, Cork, Ireland
- eCentre for Suicide Research, University Department of Psychiatry, Warneford Hospital, Oxford, UK
- fPopulation Psychiatry, Suicide and Informatics, Medical School, Swansea University, Swansea, UK
- gDepartment of Psychiatry, Aga Khan University, Karachi, Pakistan
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
No abstract is available from our sources. Use “Read paper” to view it.
TL;DRThe promise of targeting the inflammation pathway in the management of this challenging condition is today somewhat weaker, but this might not be the last word on the potential role of anti-inflammatory drugs in the treatment of bipolar depression. (Semantic Scholar)